Compare GHRS & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHRS | TPB |
|---|---|---|
| Founded | 2018 | 1988 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Tobacco |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2021 | 2015 |
| Metric | GHRS | TPB |
|---|---|---|
| Price | $29.08 | $88.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $41.38 | ★ $115.00 |
| AVG Volume (30 Days) | 304.9K | ★ 368.7K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | ★ 45.33 |
| EPS | N/A | ★ 3.11 |
| Revenue | N/A | ★ $463,062,000.00 |
| Revenue This Year | N/A | $13.68 |
| Revenue Next Year | N/A | $11.32 |
| P/E Ratio | ★ N/A | $28.68 |
| Revenue Growth | N/A | ★ 28.39 |
| 52 Week Low | $11.83 | $65.80 |
| 52 Week High | $31.44 | $146.90 |
| Indicator | GHRS | TPB |
|---|---|---|
| Relative Strength Index (RSI) | 62.73 | 61.98 |
| Support Level | $12.83 | $84.99 |
| Resistance Level | $31.00 | $92.31 |
| Average True Range (ATR) | 1.39 | 4.11 |
| MACD | 0.04 | 1.46 |
| Stochastic Oscillator | 72.08 | 86.15 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.